Guidelines for the management of inflammatory bowel disease in adults
By D. Breslin, Mark R. Driscoll, D. A. Forbes, Michael Goodfellow, Daisy Halligan, P. Hawkey, D. Hawthorne, Professor C O’Morain, D. Probert, D. Rampton and 5 more. Gut, 2004
1,689 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/738d3dbff26d2599e32df4dc0657ec1a3523d267
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics (2017, background): “An accurate discrimination between UC and CD is of relevance due to differences in treatment and management between these two entities (Mowat et al., 2011).”
- Guidelines for the management of inflammatory bowel disease in adults (2011, methodology): “They replace the guidelines published in 2004 by Carter et al.(1) They have been written with close reference to the recent European evidence-based consensus documents on Crohn’s disease and ulcerative colitis produced by the European Crohn’s and Colitis Organisation (ECCO) (https://www.”
- Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies (2017, background): “So far, no herbal extracts from plants have been certified as adjuvant medications in IBD by the International Society of Nutritional Therapy [224, 225].”